2-[2-(2-hexyldecanoyloxy)ethyl-(2-methyl-3-pyrrolidin-1-ylpropanoyl)amino]ethyl 2-hexyldecanoate
C44H84N2O5 — CID 176872641
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(2-hexyldecanoyloxy)ethyl-(2-methyl-3-pyrrolidin-1-ylpropanoyl)amino]ethyl 2-hexyldecanoate
2-[2-(2-hexyldecanoyloxy)ethyl-(2-methyl-3-pyrrolidin-1-ylpropanoyl)amino]ethyl 2-hexyldecanoate (PubChem CID 176872641) has the molecular formula C44H84N2O5 and a molecular weight of 721.16 g/mol. Its IUPAC name is 2-[2-(2-hexyldecanoyloxy)ethyl-(2-methyl-3-pyrrolidin-1-ylpropanoyl)amino]ethyl 2-hexyldecanoate.
Molecular Properties
| Compound Name | 2-[2-(2-hexyldecanoyloxy)ethyl-(2-methyl-3-pyrrolidin-1-ylpropanoyl)amino]ethyl 2-hexyldecanoate |
|---|---|
| PubChem CID | 176872641 |
| Molecular Formula | C44H84N2O5 |
| Molecular Weight | 721.16 g/mol |
| Exact Mass | 720.64 |
| IUPAC Name | 2-[2-(2-hexyldecanoyloxy)ethyl-(2-methyl-3-pyrrolidin-1-ylpropanoyl)amino]ethyl 2-hexyldecanoate |
| SMILES | CCCCCCCCC(CCCCCC)C(=O)OCCN(CCOC(=O)C(CCCCCC)CCCCCCCC)C(=O)C(C)CN1CCCC1 |
| InChI | InChI=1S/C44H84N2O5/c1-6-10-14-18-20-24-30-40(28-22-16-12-8-3)43(48)50-36-34-46(42(47)39(5)38-45-32-26-27-33-45)35-37-51-44(49)41(29-23-17-13-9-4)31-25-21-19-15-11-7-2/h39-41H,6-38H2,1-5H3 |
| InChIKey | JIQHBGMKAFTPEA-UHFFFAOYSA-N |
| XLogP | 11.31 |
| TPSA | 76.15 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 721.16 |
| LogP ≤ 5 | 11.31 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176872641 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.